Please assess the completion status of the following clinical trial:

Trial Title: Maintenance Intravenous Fluids in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* All children (3 months to 12 years) who are admitted to pediatric ward or pediatric ICU, who require exclusive intravenous maintenance fluid therapy for at least 24 hours will be eligible for the study~Exclusion Criteria:~* Children with illness that have primary fluid and electrolyte imbalance such as:~  * Shock: Defined as acute circulatory failure resulting in decreased tissue perfusion and manifesting as altered sensorium, hypothermia (\<35oC), tachycardia, prolonged capillary filling time (\>3 seconds), hypotension (BP \< 5th percentile for age), oliguria (\<0.5 ml/kg/hr), hypoxemia, hyperlactatemia, requirement of fluid bolus and/ or vasopressors.~ * Diarrhea and Dehydration: Children presenting with diarrhea and features of dehydration: lethargy, irritability and altered sensorium, thirst, decreased urine output, sunken eyes \& dry mucous membranes, loss of skin elasticity.; children with ongoing diarrhea will be excluded even if there is no dehydration.~ * Fluid Overload: Cirrhosis, Congestive heart failure, Acute and Chronic renal failure, Nephrotic syndrome.~* Abnormal serum sodium or Hyperglycemia at Presentation:~  * Hyponatremia : serum sodium \< 130 mmol/L.~ * Hypernatremia : serum sodium \>150 mmol/L.~ * Hyperglycemia: blood glucose \> 180 mg/ dl.~* Severe Protein Energy Malnutrition: Defined as grade III (50-59% of expected weight for age) and grade IV (less than 50% of expected weight for age) as per IAP classification.~* Child who is receiving drugs which cause abnormality in serum sodium such as diuretics, vasopressin, etc.

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Isotonic fluid group (Type: ACTIVE_COMPARATOR): Normal saline in 5% dextrose at standard maintenance rate
- Fluid restriction group (Type: ACTIVE_COMPARATOR): Reduced volume (2/3 maintenance rate) of N/5 saline in 5% dextrose
- Hypotonic fluid group (Type: ACTIVE_COMPARATOR): N/5 saline in 5% dextrose at standard maintenance rate

Based on this trial design, predict the completion outcome and termination type (if applicable).